1. Home
  2. IXHL vs GNS Comparison

IXHL vs GNS Comparison

Compare IXHL & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IXHL
  • GNS
  • Stock Information
  • Founded
  • IXHL 2001
  • GNS 2002
  • Country
  • IXHL Australia
  • GNS Singapore
  • Employees
  • IXHL N/A
  • GNS N/A
  • Industry
  • IXHL
  • GNS Other Consumer Services
  • Sector
  • IXHL
  • GNS Real Estate
  • Exchange
  • IXHL Nasdaq
  • GNS Nasdaq
  • Market Cap
  • IXHL 20.5M
  • GNS 17.8M
  • IPO Year
  • IXHL N/A
  • GNS 2022
  • Fundamental
  • Price
  • IXHL $0.21
  • GNS $1.37
  • Analyst Decision
  • IXHL
  • GNS
  • Analyst Count
  • IXHL 0
  • GNS 0
  • Target Price
  • IXHL N/A
  • GNS N/A
  • AVG Volume (30 Days)
  • IXHL 35.9M
  • GNS 14.3M
  • Earning Date
  • IXHL 05-15-2025
  • GNS 04-30-2025
  • Dividend Yield
  • IXHL N/A
  • GNS N/A
  • EPS Growth
  • IXHL N/A
  • GNS N/A
  • EPS
  • IXHL N/A
  • GNS N/A
  • Revenue
  • IXHL $98,000.00
  • GNS $7,912,718.00
  • Revenue This Year
  • IXHL $3,817.06
  • GNS $233.65
  • Revenue Next Year
  • IXHL $66.67
  • GNS $570.20
  • P/E Ratio
  • IXHL N/A
  • GNS N/A
  • Revenue Growth
  • IXHL N/A
  • GNS N/A
  • 52 Week Low
  • IXHL $0.08
  • GNS $0.21
  • 52 Week High
  • IXHL $3.12
  • GNS $3.20
  • Technical
  • Relative Strength Index (RSI)
  • IXHL 46.19
  • GNS 78.43
  • Support Level
  • IXHL $0.20
  • GNS $0.61
  • Resistance Level
  • IXHL $0.23
  • GNS $1.54
  • Average True Range (ATR)
  • IXHL 0.02
  • GNS 0.20
  • MACD
  • IXHL 0.01
  • GNS 0.10
  • Stochastic Oscillator
  • IXHL 13.91
  • GNS 85.83

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.

Share on Social Networks: